Archival formalin-fixed, paraffin-embedded (FFPE) tissue samples were stained for CK17 (Anti-Cytokeratin 17, Rabbit Monoclonal, clone EP1623, dilution 1:100, ab109725, Abcam, Cambridge, United Kingdom), PD-L1 (clone 22C3 for the discovery cohort and clone E1L33N for the validation cohort, respectively), and p16 (E6H4). Both a rabbit monoclonal and polyclonal CK17 antibody (ab109725 and ab53707, respectively) underwent extensive validation using CK17 highly expressing human SCC tissue and CK17 negative tonsil tissue as well as CK17 wild-type and knock-out mouse tissue (as previously described in [22 (link)]). Ultimately, clone ab109725 was selected based on the highest specificity for CK17. HPV status was determined based on p16 status for oropharyngeal tumors [24 ] and high-risk HPV RNA in situ hybridization for non-oropharyngeal tumors [25 (link)]. Detailed protocols are available in Supplemental Data S1.
Free full text: Click here